KRAS somatic mutations affecting codons 12 and 13 are found in 30–40% of colorectal cancer (CRC) and other solid tumors. KRAS mutations contribute to treatment of anti-epidermal growth factor receptor (EGFR) of metastatic colorectal cancer (mCRC).
KRAS somatic mutations affecting codons 12 and 13 are found in 30–40% of colorectal cancer (CRC) and other solid tumors. KRAS mutations contribute to treatment of anti-epidermal growth factor receptor (EGFR) of metastatic colorectal cancer (mCRC).
Why choose NoorDx?
Rapid
Delivering results in days
Innovative
Pioneering solutions in genomics testing to save lives
Confidential
Providing the highest levels of patient privacy and advanced data security
World-class
Granting access to a team of expert genetics within our state-of-the-art lab